C000157187 Fees and Costs — ProShares UltraPro Nasdaq Biotechnology
Data updated: 2020-04-28
The net expense ratio is 0.95%: a 0.75% management fee plus 0.61% other expenses, less a 0.41% fee waiver. There are no sales loads or redemption fees. In fiscal 2019 the fund paid $3K in broker commissions, 0.0102% of average net assets, and portfolio turnover was 32%.
C000157187 Fees and Expenses
Annual operating expenses and sales charges of C000157187. Prospectus, as of September 30, 2019.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | — |
| Other expenses | 0.61% |
| Gross expense ratio | 1.36% |
| Fee waiver | −0.41% |
| Net expense ratio | 0.95% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
C000157187 Costs Over Time
On $10,000 invested in C000157187, assuming 5% a year before costs, total costs come to $601 over 5 years, cutting the return by 1.01% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.95%) | $100 | $311 | $540 |
| Trading costs (broker commissions) | $1 | $3 | $6 |
| Lost growth on money paid in costs | $0 | $16 | $55 |
| Total costs | $101 | $330 | $601 |
| Value after costs | $10,399 | $11,246 | $12,162 |
| Impact on return, per year | 1.01% | 1.01% | 1.01% |
C000157187 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending May 31, 2019.
- Explicit cost rate (commissions ÷ average net assets): 0.0102%
- Total broker commissions: $3K
- Bought from dealers (principal trades, not a cost): $31.0M
- Portfolio turnover (prospectus): 32%
- Securities on loan, average value: $501K
- Net income from securities lending: $9K (0.027% of average net assets)
C000157187 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Deutsche Bank AG | $2K | 63.73% |
| JPMorgan Chase & Co. | $600 | 18.39% |
| Bank of America Corp | $583 | 17.87% |
C000157187 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BANK OF AMERICA CORP. | $28.7M | 92.49% |
| VIRTU FINANCIAL BD LLC | $2.0M | 6.37% |
| JPMORGAN CHASE & CO. | $336K | 1.08% |
| National Securities Clearing Corp. | $14K | 0.04% |
| DEUTSCHE BANK AG | $2K | 0.01% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.